Brief: Wuyi International Pharmaceutical Co announces suspension of production of Haixi plant
Nov 8 (Reuters) - Wuyi International Pharmaceutical Co Ltd
1889.HK :
* Currently organizing various professional teams to repair
haixi plant as soon as possible
* Suspension will have a substantial negative impact on
group's sales for second half of 2016
* Expects inventory that group had previously stocked up
will be able to meet short-term market demand
* Suspension will not have a material impact on group's
financial position and cash flow for year 2016
Source text for Eikon: ID:nHKS5PKk0R
Further company coverage: 1889.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Sanai Health Industry
See all newsBrief: Sanai Health Industry Says She Hao Resigned As Executive Director And Deputy CEO
Brief: Sanai Health Industry Gets Final Judgement Regarding Second Appeal From High People's Court Of Beijing
Brief: Sanai Health Industry Group Co Expects Loss Of RMB25.5 Million-RMB27.5 Million For Year
Brief: Sanai Health Industry's Unit To Sell 99% Equity Interest In Luannan Hangyang Health Industry
Brief: Sanai Health Industry Expects HY Loss Attributable Of RMB11.5 Million And RMB14.0 Million